{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:05:18Z","timestamp":1777500318083,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd004139","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,7,20]],"date-time":"2005-07-20T00:00:00Z","timestamp":1121817600000}}],"reference-count":79,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004139.pub2","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T13:18:45Z","timestamp":1120483125000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Colony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemia"],"prefix":"10.1002","volume":"2012","author":[{"given":"Emma C","family":"Sasse","sequence":"first","affiliation":[{"name":"UNICAMP (Universidade Estadual de Campinas); Internal Medicine; Av Dr. Luiz de Tella, 1515 Cidade Universitaria Campinas S\u00e3o Paulo Brazil 13083 000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre D","family":"Sasse","sequence":"additional","affiliation":[{"name":"UNICAMP (Universidade Estadual de Campinas); Internal Medicine; Av Dr. Luiz de Tella, 1515 Cidade Universitaria Campinas S\u00e3o Paulo Brazil 13083 000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia R","family":"Brandalise","sequence":"additional","affiliation":[{"name":"Centro Infantil Boldrini; Centro Infantil Boldrini, Rua Gabriel Porto, 1270 Cidade Univesit\u00e1ria Campinas S\u00e3o Paulo Brazil 13083-210"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otavio Augusto Camara","family":"Clark","sequence":"additional","affiliation":[{"name":"Scientific Solutions in Healthcare; EVIDENCIAS; Av. Dr. Luis de Tella Campinas San Paolo Brazil 1570"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Richards","sequence":"additional","affiliation":[{"name":"Oxford University; Clinical Trials Services Unit; Woodstock Road Oxford UK OX2 6HE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,20]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD004139.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajh.2830470106","article-title":"Concurrent RhGM-CSF does not offset myelosuppression from intensive chemotherapy: randomized placebo-controlled study in childhood acute lymphoblastic leukemia","volume":"47","author":"Calderwood","year":"1994","journal-title":"American Journal of Hematology"},{"issue":"5","key":"10.1002\/14651858.CD004139.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<331::AID-MPO4>3.0.CO;2-M","article-title":"Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia","volume":"32","author":"Clarke","year":"1999","journal-title":"Medical Pediatric Oncology"},{"issue":"2","key":"10.1002\/14651858.CD004139.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0609.1995.tb01816.x","article-title":"Assessment of the value of treatment with granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial","volume":"55","author":"Dibenedetto","year":"1995","journal-title":"European Journal of Haematology"},{"issue":"7","key":"10.1002\/14651858.CD004139.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1200\/JCO.2000.18.7.1517","article-title":"Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia","volume":"18","author":"Michel","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"25","key":"10.1002\/14651858.CD004139.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199706193362503","article-title":"Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia","volume":"336","author":"Pui","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004139.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1182\/blood.V87.8.3143.bloodjournal8783143","article-title":"A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Munster Study Group","volume":"87","author":"Welte","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD004139.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/(SICI)1096-8652(199805)58:1<20::AID-AJH4>3.0.CO;2-2","article-title":"High-dose cytarabine-containing chemotherapy with or without granulocyte colony-stimulating factor for children with acute leukemia","volume":"58","author":"Chen","year":"1998","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1200\/JCO.2003.07.129","article-title":"Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: A Children's Cancer Group Study","volume":"21","author":"Heath","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD004139.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1200\/JCO.1998.16.2.522","article-title":"Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: a Pediatric Oncology Group pilot study","volume":"16","author":"Laver","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD004139.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/mpo.1279","article-title":"A randomised study of prophylactic G-CSF following MRC UKALL XI intensification regimen in childhood ALL and T-NHL","volume":"38","author":"Little","year":"2002","journal-title":"Medical Pediatric Oncology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0011|cit11","first-page":"73","article-title":"A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group","volume":"58","author":"Ohno","year":"1993","journal-title":"International Journal of Hematology"},{"issue":"5","key":"10.1002\/14651858.CD004139.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1096-911X(200005)34:5<319::AID-MPO2>3.0.CO;2-5","article-title":"Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children","volume":"34","author":"Saarinen-Pihkala","year":"2000","journal-title":"Medical Pediatric Oncology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0013|cit13","first-page":"160","article-title":"Current considerations in the management of fever and neutropenia","volume":"19","author":"Alexander","year":"1999","journal-title":"Current Clinical Topics of Infectious Diseases"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0014|cit14","first-page":"77","article-title":"Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF","volume":"2","author":"Alvarado Ibarra","year":"1999","journal-title":"Revista de Investigacion Clinica"},{"issue":"1","key":"10.1002\/14651858.CD004139.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/514512","article-title":"Early discharge of low-risk febrile neutropenic children and adolescents with cancer","volume":"25","author":"Aquino","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD004139.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1182\/blood.V92.12.4491","article-title":"Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor","volume":"92","author":"Armitage","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD004139.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1097-0142(19940701)74:1<189::AID-CNCR2820740130>3.0.CO;2-7","article-title":"Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia","volume":"74","author":"Bash","year":"1994","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD004139.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s002100000390","article-title":"Effect of myelopoieetic and pleiotropic cytokines on colony formation by bast cells of children with acute lymphoblastic leukemia","volume":"363","author":"Benki","year":"2001","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<92::AID-MPO3>3.0.CO;2-Q","article-title":"Cost analysis of filgrastim for prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials","volume":"34","author":"Bennett","year":"2000","journal-title":"Medical Pediatric Oncology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/07357909809115775","article-title":"A comparison of efficacy of sargramostin (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression","volume":"6","author":"Beveridge","year":"1998","journal-title":"Cancer Investigation"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0277-5379(90)90613-X","article-title":"Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever","volume":"26","author":"Biesma","year":"1990","journal-title":"European Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD004139.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651850","article-title":"Granulopoiesis-stimulating factor to prevent adverse effects in the treatment of malignant lymphoma.","author":"Bohlius","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/1097-0142(19950801)76:3<510::AID-CNCR2820760323>3.0.CO;2-W","article-title":"Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study","volume":"76","author":"Burdach","year":"1995","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1590\/S1516-31801999000300011","article-title":"Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature database (LILACS database): update","volume":"117","author":"Castro","year":"1999","journal-title":"Sao Paulo Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD004139.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0891-5520(05)70326-3","article-title":"Fever in the neutropenic host","volume":"10","author":"Chanock","year":"1996","journal-title":"Infectious Diseases Clinics of North America"},{"issue":"1","key":"10.1002\/14651858.CD004139.pub2-BIB0026|cit26","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia","author":"Clark","year":"2005","journal-title":"The Cochrane Library"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trial","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"6964","key":"10.1002\/14651858.CD004139.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"7109","key":"10.1002\/14651858.CD004139.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0030|cit30","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926","volume-title":"Systematic Reviews in Health Care","author":"Egger","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s005200100300","article-title":"Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices","volume":"10","author":"Elting","year":"2002","journal-title":"Supportive Care in Cancer"},{"issue":"6","key":"10.1002\/14651858.CD004139.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1200\/JCO.1991.9.6.1022","article-title":"Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy","volume":"9","author":"Furman","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jnci\/93.1.31","article-title":"Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial","volume":"93","author":"Garcia-Carbonero","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0034|cit34","first-page":"141","article-title":"Human granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens","volume":"3","author":"Gattei","year":"1997","journal-title":"Cytokines, Cellular & Molecular Therapy"},{"issue":"8777","key":"10.1002\/14651858.CD004139.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0140-6736(91)92098-M","article-title":"Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia","volume":"338","author":"Gmur","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0036|cit36","first-page":"2798","article-title":"Hematopoietic Growth Factors","volume-title":"Cancer: Principles and Practice of Oncology","volume":"1","author":"Griffin","year":"2001"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0272989X9501500112","article-title":"Meta-analytic tools for medical decision making: a practical guide","volume":"15","author":"Hasselblad","year":"1995","journal-title":"Medical Decision Making"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.leu.2400951","article-title":"Leukemic cells with 11q23 translocations express granulocyte colony-stimulating factor (G-CSF) receptor and their proliferation is stimulated with G-CSF","volume":"12","author":"Inukai","year":"1998","journal-title":"Leukemia"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.leu.2401620","article-title":"Use of thrombopoietic growth factors in acute leukemia","volume":"14","author":"Kaushansky","year":"2000","journal-title":"Leukemia"},{"issue":"9","key":"10.1002\/14651858.CD004139.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM199108293250916","article-title":"Pneumocystis carinii pneumonia developing within one month of intensive chemotherapy for treatment of acute lymphoblastic leukemia","volume":"325","author":"Kritz","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lechxin","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD004139.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/bjc.1998.216","article-title":"Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost","volume":"77","author":"Lee","year":"1998","journal-title":"British Journal of Cancer"},{"issue":"4","key":"10.1002\/14651858.CD004139.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0889-8588(05)70371-3","article-title":"Clinical use of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy","volume":"10","author":"Lifton","year":"1996","journal-title":"Hematology and Oncology of Clinics of North America"},{"issue":"6","key":"10.1002\/14651858.CD004139.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/stem.5530120606","article-title":"The structure, biology and potential therapeutic applications of recombinant thrombopoietin","volume":"12","author":"Lok","year":"1994","journal-title":"Stem Cell"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0047|cit47","first-page":"349","article-title":"G-CSF after autologous bone marrow transplantation for malignant diseases in children. Spanish Working Party for Bone Marrow Transplantation in Children","volume":"15","author":"Madero","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-121-7-199410010-00004","article-title":"Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial","volume":"121","author":"Maher","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"87","key":"10.1002\/14651858.CD004139.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/87.11.803","article-title":"Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors","volume":"11","author":"Mayordomo","year":"1995","journal-title":"Journal of the National Cancer Institute"},{"issue":"9","key":"10.1002\/14651858.CD004139.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-126-9-199705010-00007","article-title":"Using numerical results from systematic reviews in clinical practice","volume":"126","author":"McQuay HJ","year":"1997","journal-title":"Annals of Internal Medicine"},{"issue":"9296","key":"10.1002\/14651858.CD004139.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/S0140-6736(01)06891-X","article-title":"Industry-sponsored clinical research: a double-edged sword","volume":"358","author":"Montaner","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mpo.2950200708","article-title":"RhGM-CSF in bone marrow transplantation: experience in pediatric patients","volume":"Supp 2","author":"Nemunaitis","year":"1992","journal-title":"Medical Pediatric Oncology"},{"issue":"1-2","key":"10.1002\/14651858.CD004139.pub2-BIB0053|cit53","first-page":"73","article-title":"A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group","volume":"58","author":"Ohno","year":"1993","journal-title":"International Journal of Hematology"},{"issue":"20","key":"10.1002\/14651858.CD004139.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","article-title":"2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel","volume":"18","author":"Ozer","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0055|cit55","first-page":"1016","article-title":"Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients","volume":"11","author":"Palmeri","year":"1999","journal-title":"Haematologica"},{"issue":"1","key":"10.1002\/14651858.CD004139.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00008480-200002000-00003","article-title":"Oncology practice patterns in the use of hematopoietic growth factors","volume":"12","author":"Parsons","year":"2000","journal-title":"Current Opinion in Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD004139.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/mpo.2950210509","article-title":"Fever and granulocytopenia in children with cancer: a study of 299 episodes with two treatment protocols in Brazil","volume":"21","author":"Petrilli","year":"1993","journal-title":"Medical Pediatric Oncology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0058|cit58","article-title":"Colony-Stimulating Factors","volume-title":"Cancer Chemotherapy and Biotherapy - Principles and Practice","author":"Petros","year":"2001"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1046\/j.1537-2995.2001.41121577.x","article-title":"The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSF","volume":"12","author":"Pierelli","year":"2001","journal-title":"Transfusion"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005792-198205000-00003","article-title":"Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes","volume":"61","author":"Pizzo","year":"1982","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1002\/14651858.CD004139.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-3476(05)80281-1","article-title":"The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies","volume":"119","author":"Pizzo","year":"1991","journal-title":"Journal of Pediatrics"},{"issue":"18","key":"10.1002\/14651858.CD004139.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","article-title":"Management of fever in patients with cancer and treatment-induced neutropenia","volume":"328","author":"Pizzo","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD004139.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM199909163411207","article-title":"Fever in immunocompromised patients","volume":"341","author":"Pizzo","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"25","key":"10.1002\/14651858.CD004139.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199706193362503","article-title":"Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia","volume":"336","author":"Pui","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004139.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.leu.2401083","article-title":"Meeting report: International Childhood ALL Workshop: Memphis, TN, 3-4 December 1997","volume":"12","author":"Pui","year":"1998","journal-title":"Leukemia"},{"issue":"10","key":"10.1002\/14651858.CD004139.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1470-2045(01)00516-2","article-title":"Childhood acute lymphoblastic leukaemia--current status and future perspectives","volume":"2","author":"Pui","year":"2001","journal-title":"Lancet Oncology"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00006454-199403000-00006","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children","volume":"13","author":"Riikonen","year":"1994","journal-title":"Pediatric Infectious Diseases Journal"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/stem.5530130310","article-title":"Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer","volume":"13","author":"Riikonen","year":"1995","journal-title":"Stem Cells"},{"issue":"4","key":"10.1002\/14651858.CD004139.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00043426-200205000-00009","article-title":"Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges","volume":"24","author":"Rosenman","year":"2002","journal-title":"Journal of Pediatric Hematology and Oncology"},{"issue":"10","key":"10.1002\/14651858.CD004139.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/jnci\/90.10.750","article-title":"Cost-minimization analysis of prophylactic granulocyte colony-stimulating factor after induction chemotherapy in children with non-Hodgkin's lymphoma","volume":"90","author":"Rubino","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1002\/14651858.CD004139.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mpo.2950200602","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor in children with chemotherapy-induced neutropenia","volume":"20","author":"Saarinen","year":"1992","journal-title":"Medical Pediatric Oncology"},{"issue":"6","key":"10.1002\/14651858.CD004139.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/(SICI)1096-911X(199606)26:6<380::AID-MPO2>3.0.CO;2-D","article-title":"Granulocyte-colony-stimulating factor after allogeneic and autologous bone marrow transplantation in children","volume":"26","author":"Saarinen","year":"1996","journal-title":"Medical Pediatric Oncology"},{"issue":"12","key":"10.1002\/14651858.CD004139.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s004310050978","article-title":"Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel","volume":"157","author":"Schaison","year":"1998","journal-title":"European Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD004139.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2141.2003.04235.x","article-title":"Clinical manifestations associated with the aberrant expression of the soluble granulocyte-macrophage colony-stimulating factor receptor in patients presenting with haematological malignancies.","volume":"121","author":"Trus","year":"2003","journal-title":"British Journal of Haematology"},{"issue":"4","key":"10.1002\/14651858.CD004139.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1200\/JCO.1995.13.4.1023","article-title":"Clinical applications of hematopoietic growth factors","volume":"13","author":"Vose","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD004139.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.bmt.1702865","article-title":"Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy:a randomized comparison of filgrastim, sargramostim, or sequencial sargramostim and filgrastim","volume":"Suppl 2","author":"Weaver","year":"2001","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004139.pub2-BIB0077|cit77","first-page":"267","article-title":"Severe chronic neutropenia: pathophysiology and therapy","volume":"34","author":"Welte","year":"1997","journal-title":"Seminars in Hematology"},{"issue":"3","key":"10.1002\/14651858.CD004139.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1200\/JCO.1996.14.3.901","article-title":"Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy","volume":"14","author":"Wexler","year":"1996","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD004139.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Programs Cardiovascular Disease"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004139.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:17:13Z","timestamp":1772039833000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004139.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,7,20]]},"references-count":79,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004139.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,20]]}}}